Innovatemed | dodge city, ks

Privacy Policy

1. Introduction

This privacy notice (“Policy”) describes the privacy practices of InnovateMed (“we,” “us,” “our”) regarding protected health information (PHI), personal data collected through our website, and health information collected in connection with clinical services.

This Policy applies to information collected online and in connection with any clinical care, treatment, or healthcare operations provided by InnovateMed and is provided in accordance with federal law, including the Health Insurance Portability and Accountability Act (HIPAA) and amendments incorporating 42 CFR Part 2.

We are a healthcare provider offering medical aesthetic and clinical services, and therefore medical privacy and patient rights protections apply to the information we collect and maintain.

2. Information Collection, Use, and Sharing

We collect information that you voluntarily provide to us through:

  • Website form submissions
  • Appointment scheduling
  • Email or phone contact
  • Clinical intake forms
  • Treatment consultations and planning

We may also collect technical data through cookies, tracking pixels, analytics tools, and similar technologies to support website functionality and performance.

Uses of Data

We may use collected information to:

  • Provide clinical care, treatment, and healthcare operations
  • Schedule appointments and send reminders
  • Communicate about services, updates, or changes
  • Analyze and improve our services and website performance

We do not sell or lease your personal information.

We may share protected health information as permitted or required by law for treatment, payment, and healthcare operations (TPO) with appropriate consent.

For example, we may share PHI with:

  • Healthcare providers involved in your care
  • Third-party service providers supporting treatment or payment
  • Insurance providers or payers when necessary

3. HIPAA and 42 CFR Part 2 — Consent and Shared Records

Under federal law, including HIPAA and 42 CFR Part 2, we may use and disclose your protected health information for Treatment, Payment, and Healthcare Operations (“TPO”) with a single general signed consent unless a more restrictive law applies.

Substance Use Disorder Records (42 CFR Part 2)

Certain sensitive health information, including records identifying substance use disorder diagnosis or treatment, is subject to additional federal confidentiality protections.

These records may not be used or disclosed in civil, criminal, administrative, or legislative proceedings without your written consent or a qualifying court order.

Redisclosure Risk

If your information is shared with another healthcare provider or organization for care coordination or treatment, that recipient may not be bound by the same confidentiality protections that apply to us.

You may request limitations on how your information is shared.

4. Your Rights

You have the right to:

  • Access or obtain copies of your protected health information
  • Request corrections to your records
  • Request restrictions on certain uses and disclosures
  • Receive an accounting of disclosures
  • Revoke authorizations previously provided

Requests may be submitted by contacting us at:

Email: drtanya@innovatemeddc.com
Phone: (620) 412-8943

5. Biometric and Imaging Data Consent

InnovateMed may collect high-resolution photography, digital imaging, and biometric templates used for:

  • Treatment planning
  • Clinical assessment
  • Medical documentation
  • Monitoring of treatment outcomes

By providing these images and data, you expressly consent to their collection, use, and storage for clinical care and internal quality improvement purposes.

We do not sell or lease biometric data to third parties.

6. Data Security and Communication Risks

We implement administrative, technical, and physical safeguards to protect your information.

However, please be aware that:

  • Standard email and SMS communications are not encrypted, and choosing these methods carries a risk that messages could be intercepted.
  • Communications through third-party platforms (such as scheduling or marketing systems) may have privacy practices separate from our own.

By opting into email or SMS communication, you acknowledge these potential risks.

7. Marketing and Non-Clinical Communication Opt-Out

If we use your contact information for marketing communications, newsletters, or promotional messaging, you have the right to opt out at any time.

  • Email messages include an unsubscribe link.
  • Text messages may be opted out of by replying STOP.

You may also request removal from marketing communications by contacting:

drtanya@innovatemeddc.com

8. Cookies, Tracking, and Analytics

Our website may use cookies and similar technologies to:

  • Improve website functionality
  • Personalize user experience
  • Support analytics and performance measurement

You may disable cookies through your browser settings, although doing so may affect website functionality.

9. Updates to This Policy

We may update this Policy periodically to reflect changes in legal requirements, clinical practices, or operational processes.

The effective date at the top of this document will be revised when updates occur. Continued use of our services after updates are posted constitutes acceptance of the revised Policy.

10. Contact and Complaints

If you believe your privacy rights have been violated, you may contact us at:

InnovateMed
2400 N 14th Ave
Dodge City, KS 67801

Email: drtanya@innovatemeddc.com
Phone: (620) 412-8943

You may also file a complaint with the U.S. Department of Health and Human Services Office for Civil Rights.